EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Baseline surveillance in Li Fraumeni syndrome using whole-body MRI: a systematic review and updated meta-analysis

Maria Inez Dacoregio, Pedro Cotta Abrahão Reis, Davi Said Gonçalves Celso, Lorena Escalante Romero, Stephan Altmayer, Maysa Vilbert, Fabio Ynoe Moraes, Israel Gomy

European Radiology · 2024

DOI: 10.1007/s00330-024-10983-2 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Radiology, 2024. Verfasst von Maria Inez Dacoregio und 7 weiteren Autor:innen. Beteiligte Einrichtung: State University of Centro Oeste (UNICENTRO), Guarapuava, PR, Brazil. mdacoregio@unicentro.edu.br. Hauptthemen laut MEDLINE: Li-Fraumeni Syndrome, Whole Body Imaging, Magnetic Resonance Imaging, Early Detection of Cancer. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Li-Fraumeni syndrome (LFS) is a cancer syndrome associated with early-onset neoplasias. The use of whole-body magnetic resonance imaging (WBMRI) is recommended for regular cancer screening, however, evidence supporting the benefits in asymptomatic LFS patients is limited. This study aims to assess the clinical utility of WBMRI in germline TP53 mutation carriers at baseline and follow-up. MATERIALS AND METHODS: We systematically searched PubMed, Cochrane, and Embase databases for studies evaluating WBMRI as an early detection method for tumor screening in patients with LFS. We pooled the prevalence of the included variables along with their corresponding 95% confidence intervals (CIs). Statistical analyses were performed using R software, version 4.3.1. RESULTS: From 1687 results, 11 comprising 703 patients (359 females (51%); with a median age of 32 years (IQR 1-74)) were included. An estimated detection rate of 31% (95% CI: 0.28, 0.34) for any suspicious lesions was found in asymptomatic TP53 carriers who underwent baseline WBMRI. A total of 277 lesions requiring clinical follow-up were identified in 215 patients. Cancer was confirmed in 46 lesions across 39 individuals. The estimated cancer diagnosis rate among suspicious lesions was 18% (95% CI: 0.13, 0.25). WBMRI detected 41 of the 46 cancers at an early-disease stage, with an overall detection rate of 6% (95% CI: 0.05, 0.08). The incidence rate was 2% per patient round of WBMRI (95% CI: 0.01, 0.04), including baseline and follow-up. CONCLUSION: This meta-analysis provides evidence that surveillance with WBMRI is effective in detecting cancers in asymptomatic patients with LFS. CLINICAL RELEVANCE STATEMENT: Our study demonstrates that whole-body MRI is an effective tool for early cancer detection in asymptomatic Li-Fraumeni Syndrome patients, highlighting its importance in surveillance protocols to improve diagnosis and treatment outcomes. KEY POINTS: Current evidence for whole-body MRI screening of asymptomatic Li-Fraumeni Syndrome (LFS) patients remains scarce. Whole-body MRI identified 41 out of 46 cancers at an early stage, achieving an overall detection rate of 6%. Whole-body MRI surveillance is a valuable method for detecting cancers in asymptomatic LFS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Li-Fraumeni SyndromeWhole Body ImagingMagnetic Resonance ImagingEarly Detection of CancerHumansFemaleAdultMaleChild

Stichwörter der Autor:innen

Cancer screeningEarly detection cancerLi-Fraumeni syndromeTumor suppressor protein p53Whole-body imaging

Autor:innen und Institutionen

  • State University of Centro Oeste (UNICENTRO), Guarapuava, PR, Brazil. mdacoregio@unicentro.edu.br.
  • Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  • Federal University of Viçosa (UFV), Viçosa, MG, Brazil.
  • Oncology Pediatrics Department, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
  • Radiology Department, Stanford University, Stanford, CA, US.
  • Massachusetts General Hospital Cancer Center, Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, US.

Zitieren

APA

Dacoregio, M. I., Abrahão Reis, P. C., Gonçalves Celso, D. S., Romero, L. E., Altmayer, S., Vilbert, M., Moraes, F. Y., & Gomy, I. (2024). Baseline surveillance in Li Fraumeni syndrome using whole-body MRI: a systematic review and updated meta-analysis. European Radiology. https://doi.org/10.1007/s00330-024-10983-2

Vancouver

Dacoregio MI, Abrahão Reis PC, Gonçalves Celso DS, Romero LE, Altmayer S, Vilbert M, et al. Baseline surveillance in Li Fraumeni syndrome using whole-body MRI: a systematic review and updated meta-analysis. European Radiology. 2024. doi:10.1007/s00330-024-10983-2

BibTeX
@article{Dacoregio2024,
  author = {Dacoregio, Maria Inez and Abrahão Reis, Pedro Cotta and Gonçalves Celso, Davi Said and Romero, Lorena Escalante and Altmayer, Stephan and Vilbert, Maysa and Moraes, Fabio Ynoe and Gomy, Israel},
  title = {Baseline surveillance in Li Fraumeni syndrome using whole-body MRI: a systematic review and updated meta-analysis},
  journal = {European Radiology},
  year = {2024},
  doi = {10.1007/s00330-024-10983-2}
}
Kostenlos starten →